Envestnet Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
28,137
+3,094
| +12% | +$323K | ﹤0.01% | 2547 |
|
|
2025
Q1 | $2.92M | Sell |
25,043
-10,086
| -29% | -$1.18M | ﹤0.01% | 2476 |
|
|
2024
Q4 | $2.97M | Buy |
35,129
+15,047
| +75% | +$1.27M | ﹤0.01% | 2451 |
|
|
2024
Q3 | $1.8M | Sell |
20,082
-586
| -3% | -$52.7K | ﹤0.01% | 2733 |
|
|
2024
Q2 | $1.66M | Buy |
20,668
+813
| +4% | +$65.4K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $1.58M | Buy |
19,855
+4,263
| +27% | +$340K | ﹤0.01% | 2721 |
|
|
2023
Q4 | $1.24M | Sell |
15,592
-346
| -2% | -$27.5K | ﹤0.01% | 2776 |
|
|
2023
Q3 | $1.11M | Buy |
15,938
+3,008
| +23% | +$210K | ﹤0.01% | 2738 |
|
|
2023
Q2 | $929K | Buy |
12,930
+2,457
| +23% | +$177K | ﹤0.01% | 2810 |
|
|
2023
Q1 | $646K | Sell |
10,473
-1,548
| -13% | -$95.5K | ﹤0.01% | 2978 |
|
|
2022
Q4 | $927K | Sell |
12,021
-2,760
| -19% | -$213K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $660K | Buy |
14,781
+3,949
| +36% | +$176K | ﹤0.01% | 2851 |
|
|
2022
Q2 | $415K | Buy |
10,832
+3,104
| +40% | +$119K | ﹤0.01% | 3162 |
|
|
2022
Q1 | $320K | Sell |
7,728
-1,130
| -13% | -$46.8K | ﹤0.01% | 3413 |
|
|
2021
Q4 | $335K | Sell |
8,858
-3,308
| -27% | -$125K | ﹤0.01% | 3343 |
|
|
2021
Q3 | $401K | Buy |
12,166
+531
| +5% | +$17.5K | ﹤0.01% | 3112 |
|
|
2021
Q2 | $785K | Buy |
11,635
+2,336
| +25% | +$158K | ﹤0.01% | 2688 |
|
|
2021
Q1 | $527K | Buy |
+9,299
| New | +$527K | ﹤0.01% | 2812 |
|